CTAS' first-quarter fiscal 2025 organic revenues increase 8% year over year on solid segmental sales.

MLKN's first-quarter fiscal 2025 results reflect soft housing demand trends marring growth prospects across the segments and increased operating...

HealthEquity (HQY) could produce exceptional returns because of its solid growth attributes.

DRI's first-quarter fiscal 2025 top line benefits from new restaurant openings. Yet, dismal same-restaurant sales dampen overall growth.

FDX's first-quarter fiscal 2025 earnings and revenues decline year over year.

DRI's first-quarter fiscal 2025 performance is likely to have benefited from menu simplifications, unit-expansion efforts and Ruth's Chris...

The mean of analysts' price targets for HealthEquity (HQY) points to a 32.9% upside in the stock. While this highly sought-after metric has not proven...

Growth in PEO and insurance solutions and higher interest on clients' funds are anticipated to have benefited PAYX's first-quarter fiscal 2025...

THO reports better-than-expected results for Q4 fiscal 2024 and expects its fiscal 2025 consolidated net sales in the range of $9-$9.8 billion.

General Mills' first-quarter fiscal 2025 results reflect lower earnings and sales due to the adverse net price realization and mix.